Grail | search
Click here to view Grail news from 60+ newspapers.
Bookmark or Share- Homepage - GRAILGRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.
- Multi-cancer early detection - GRAILGRAIL uses advanced machine learning algorithms and pattern recognition to “read” methylation patterns. Using these two principles, the Galleri test has three scientific steps: Extract and sequence the DNA fragments from the blood to “read” the methylation patterns (assay)
- Patient Reported Outcomes for GRAIL’s Galleri® Multi-Cancer Early ...GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring.
- Megan Hall - GRAILMegan P. Hall, PhD is Vice President of Medical & Corporate Affairs, and a Distinguished Scientist, at GRAIL, where she leads the Medical Affairs team on overall strategy and tactical execution to ensure broad adoption of our multi-cancer early detection test.
- Careers - GRAILEverything we do is guided by our mission to detect cancer early, when it can be cured. We have a group of people at GRAIL whose talent, commitment, and creativity are unmatched. And as we grow, we’re looking for people who will increase the impact we can make on the world.
More
